Upcoming FEBS Open Bio Webinar: The structures of SARS-CoV-2 proteins

We are pleased to announce the first free FEBS Open Bio webinar, which will be held on Zoom on 3rd November 2022 at 13:00 CET (12:00 GMT). This webinar will be a roundtable discussion on the structures of SARS-CoV-2 proteins, hosted by Prof. Alexander Wlodawer. We look forward to seeing you there!
Upcoming FEBS Open Bio Webinar: The structures of SARS-CoV-2 proteins
Like

Share this post

Choose a social network to share with, or copy the shortened URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Update! Watch the recording of this webinar on the FEBS Open Bio journal website.

FEBS Open Bio webinar poster

To tie in with our recent special issue, FEBS Open Bio is holding a free webinar on the structures of SARS-CoV-2 proteins on Thursday 3rd November 2022 at 13:00 CET (12:00 GMT) for 45 minutes.

The webinar will feature a roundtable discussion between the guest editor (webinar chair Prof. Alexander Wlodawer, National Cancer Institute, MD, USA) and the corresponding authors of the articles in the special issue:  Prof. Robin Stanley (National Institute of Environmental Health Sciences, NC, USA), Prof. Xinquan Wang(Tsinghua University, Beijing, China), and Prof. Franck Martin (Université de Strasbourg, France).

We invite you to join us for this exciting conversation on the important advances, ongoing challenges, and unanswered questions in the field of coronavirus protein structure. Questions can be asked during the event, and we also invite attendees to send questions to the speakers in advance by sending them by email to [email protected]

Please register for free at the link here: https://zoom.us/webinar/register/WN_BbrARfWKSmOjjASrQ3aydA

We look forward to seeing you there!


Join the FEBS Network today

Joining the FEBS Network’s molecular life sciences community enables you to access special content on the site, present your profile, 'follow' contributors, 'comment' on and 'like' content, post your own content, and set up a tailored email digest for updates.